Aberdeen Group plc Buys 38,952 Shares of Omega Healthcare Investors, Inc. $OHI

Aberdeen Group plc increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.5% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,166,202 shares of the real estate investment trust’s stock after acquiring an additional 38,952 shares during the quarter. Aberdeen Group plc’s holdings in Omega Healthcare Investors were worth $42,193,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Omega Healthcare Investors by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock worth $1,506,250,000 after buying an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Omega Healthcare Investors by 2.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust’s stock worth $156,162,000 after purchasing an additional 114,665 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Omega Healthcare Investors by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock worth $154,533,000 after purchasing an additional 165,554 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Omega Healthcare Investors by 6.4% in the 1st quarter. Bank of New York Mellon Corp now owns 3,123,152 shares of the real estate investment trust’s stock worth $118,930,000 after purchasing an additional 188,481 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock worth $108,989,000 after purchasing an additional 2,322,878 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on OHI. Mizuho lifted their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, September 11th. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a research note on Thursday, August 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company lifted their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. Seven analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $44.44.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares in the company, valued at $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $39.83 on Monday. The firm has a 50 day moving average of $41.57 and a 200-day moving average of $38.82. The stock has a market capitalization of $11.75 billion, a PE ratio of 24.59, a PEG ratio of 1.86 and a beta of 0.70. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating the consensus estimate of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.7%. Omega Healthcare Investors’s payout ratio is presently 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.